Clinical and laboratory features of viral hepatitis B among HIV-patients in Zambia

  • L. V. Moroz National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • S. Ch. Soni National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • K. D. Chichirelo-Konstantynovych National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • S. M. Kulias National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • O. O. Popovych National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: viral hepatitis B, HIV-infection, Zambia, clinical features, laboratory features, course


Viral hepatitis B course in HIV patients in Zambia is still bad studied. At present, the study of the influence of immunosuppression on the clinical and laboratory features of viral hepatitis B acquires a special relevance. The aim of research is to investigate clinical and laboratory features of viral hepatitis B course among HIV-patients in Zambia. Epidemiological, descriptive, serological (HBV, HIV markers), biochemical (cytolysis and cholestasis syndromes’ indicators), statistic method for determining the reliability using average errors (m), t-criterion of the probability difference of the Student) methods are used. The results show HBV/HIV-positive Zambian patients reliably differ from HBV-monoinfected ones. As well, HBV/HIV-positive patients have significantly higher indexes of asteno-vegetatic, dyspeptic syndromes, hepato- and splenomegaly, cytolysis indexes (alanine aminotransferase, lactate dehydrogenase), which are associated with increase of HIV-infection’s stage. Hepatocellular deficiency’s indicators don’t differ reliably in comparison groups. Therefore, HBV/HIV-infected patients have more severe clinical and laboratory course than HBV-monoinfected ones.


1. Androsova, O. S. (2015). Morfolohichni osoblyvosti urazhennia pechinky u VIL-infikovanykh khvorykh na tli koinfikuvannia hepatotropnymy virusamy ta pryiomu vysokoaktyvnoi antyretrovirusnoi terapii [Morphological features of liver disease in HIV-infected patients during coinfection with hepatotropic viruses and receiving highly active anti retroviral therapy]. Visnyk morfolohii – Reports of Morphology, 21 (1), 135–139.

2. Moroz, L. V., Chichirelo-Konstantynovych, K. D., & Kulias, S. M. (2018). Virusnyi hepatyt G: trudnoshchi ta perspektyvy veryfikatsii, obstezhennia, likuvannia ta profilaktyky [Viral hepatitis G: difficulties and prospects of verification, examination, treatment and prevention]. Hepatolohiia – Hepatology, 2 (40), 6–15.

3. Belyhun, Y., Maier, M., & Liebert, U. G. (2017). HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia. Antivir. Ther., 22 (2), 97–11. doi: 10.3851/IMP3060.

4. Fuster, F., Vargas, J. I., Jensen, D., Sarmiento, V., Acuña, P., Peirano, F., ... Ahumada, R. (2016). CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study. Vaccine, 34 (16), 1889–1895. doi: 10.1016/j.vaccine.2016.02.055.

5. Jooste, P., van Zyl, A., Adland, E., Daniels, S., Hattingh, L., Brits, A., ... Goulder, P. (2016). Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa. Journal of Clinical Virology, 85, 71–74. doi: 10.1016/j.jcv.2016.10.017.

6. Lô, G., Sow‐Sall, A., Diop‐Ndiaye, H., Mandiouba, N. C. I. D., Thiam, M., Diop, F., ... Mbow, M. (2016). Prevalence of hepatitis B markers in Senegalese HIV‐1‐infected patients. Journal of medical virology, 88 (3), 461–465.

7. Matthews, P. C., Beloukas, A., Malik, A., Carlson, J. M., Jooste, P., Ogwu, A., ... Jaggernath, M. (2015). Prevalence and characteristics of hepatitis B virus (HBV) coinfection among HIV-positive women in South Africa and Botswana. PLoS One, 10 (7), e0134037. doi: 10.1371/journal.pone.0134037.

8. M Kibaya, R., Lihana, R., Kiptoo, M., Songok, E., Ng’ang’a, Z., Osman, S., ... Lwembe, R. (2015). Characterization of HBV among HBV/HIV-1 Co-Infected injecting drug users from Mombasa, Kenya. Current HIV research, 13 (4), 292–299. PMID:25613131.

9. Mutagoma, M., Balisanga, H., Malamba, S. S., Sebuhoro, D., Remera, E., Riedel, D. J., ... Nsanzimana, S. (2017). Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC infectious diseases, 17 (1), 618. doi:10.1186/s12879-017-2714-0.

10. Opaleye, O., Akanbi, O., & Binuyo, M. (2017). Prevalence of HBV, HIV, and HIV-HBV Co-infections among healthcare workers in Ibadan, Nigeria. BMJ Global Health, 2 (2), A45–A45. doi: 10.1097/QAI.0000000000000496.

11. Rajbhandari, R., Jun, T, Khalil, H., Chung, R. T. & Anantakrishnan, A. N, (2016). HBV/HIV coinfection is associated with poorer outcomes in hospitalized patients with HBV or HIV. Journal of viral hepatitis, 23 (10), 820–829. PMID: 27291562.

12. Maponga, T. G., Andersson, M. I., Van Rensburg, C. J., Arends, J. E., Taljaard, J., Preiser, W., & Glashoff, R. H. (2018). HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa. BMC infectious diseases, 18 (1), 214. doi: 10.1186/s12879-018-3115-8.

13. Salpini, R., Fokam, J., Ceccarelli, L., Santoro, M. M., Nanfack, A., Martin Sosso, S., ... Andreoni, M. (2016). High burden of HBV-infection and atypical HBV strains among HIV-infected Cameroonians. Current HIV research, 14 (2), 165–171. doi: 10.1371/journal.pone.0161714.

14. Stockdale, A. J., Phillips, R. O., & Geretti, A. M. (2016). The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to:‘The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa’ by Lemoine et al. Gut, 65 (5), 882–884. doi: 10.1136/gutjnl-2015-311133.
How to Cite
Moroz, L. V., Soni, S. C., Chichirelo-Konstantynovych, K. D., Kulias, S. M., & Popovych, O. O. (2019). Clinical and laboratory features of viral hepatitis B among HIV-patients in Zambia. Reports of Vinnytsia National Medical University, 23(2), 257-262.